FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/12/2023
Back to search
Official data from USPTO
ARTICE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ARTICE
ST13
US500000079328254Class
1, 5, 10, 42, 44
Filing
79328254
Registration
7051087
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
09/12/2023
Trademark type
Word
Nice classes
1, 5, 10, 42, 44
Filing date
10/07/2021
Registration date
05/16/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/16/2023
Last transaction
05/16/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
DE
Examiner
SEVERSON, JUSTIN
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Artcline GmbH
Representatives
Jeffrey H. Handelsman Greenblum & Bernstein, P.L.C.
Technical classification
Nice Classes
Class 1Class 5Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biological and biochemical preparationsin particular in form of antibodiesantibody derivativesbinding proteins and peptides for laboratory and experimentation purposesin particular for conducting experimental assaysother than for therapeutic medical or veterinary purposes
Class 5
Biological and biochemical preparations in form of antibodiesantibody derivativesbinding proteins and peptides for medical or veterinary diagnostic purposes; biological and biochemical preparations in form of bifunctional or multifunctional proteins with binding affinity to immune cellsin particular with binding affinity to T cells and natural killer (NK) cellsin particular for the subsequent targeting of cancer cells; biological and biochemical preparations for diagnostic and therapeutic usein particular in form of antibodiesantibody derivativesbinding proteins and peptides; biological and biochemical preparations in form of antibodiesantibody derivativesbinding proteins and peptides for use within the framework of experimental and medical or veterinary assays; none of the aforesaid goods in this class for use relating to kidney injury and all of the aforesaid goods in this class other than cardiovascular products
Class 10
Surgicalmedicaldental and veterinary apparatus and instruments for extracorporeal blood and plasma treatments or apheresis devices as well as infusion or transfusion devices for the treatment of infectionsin particular for the treatment of sepsis; artificial limbseyes and teeth; suture materials; therapeutic and assistive devices adapted for persons with disabilitiesextracorporeal apheresis devices; massage apparatus; apparatusdevices and articles for nursing infantsinfusion and transfusion devices; none of the aforesaid goods in this class for use relating to aneurysmsembolisation procedures or kidney injury
Class 42
Scientific and technological servicesscientific research and design in the field of immunotherapyin particular in the field of immuno-oncology; scientific and technological servicesscientific research and design in the field of virology; scientific and technological servicesscientific research and design in the field of antiinfectives; scientific and technological servicesscientific research and design in the field of neurodegenerative diseases; scientific and technological servicesscientific research and design in the field of autoimmune diseases; in particular all of the aforesaid services related to the use of antibodiesantibody derivativesbinding proteins and peptides; scientific and technological servicesscientific research and design in the field of immunotherapy by means of activating or modulating innate and adaptive immunityin particular in the field of immune-oncology
Class 44
Medical servicesin particular in the field of immunotherapyin particular in the field of immuno-oncology or relating to severe infections or sepsis; medical services in the field of virology; medical services in the field of antiinfectives; medical services in the field of neurodegenerative diseases; medical services in the field of autoimmune diseases; in particular all of the aforesaid services related to the use of antibodiesantibody derivativesbinding proteins and peptides; medical services in the field of immunotherapy by means of activating or modulating innate and adaptive immunityin particular in the field of immuno-oncology; none of the aforesaid services in this class being medical services relating to the treatment of aneurysms and all of the aforesaid services in this class other than cardiovascular products
Publications
History of USPTO decisions and trademark events.
31 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/18/2023
FIMP
FINAL DISPOSITION PROCESSED
08/18/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/16/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/16/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
05/16/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/28/2023
PUBO
PUBLISHED FOR OPPOSITION
02/28/2023
GPNX
NOTIFICATION PROCESSED BY IB
02/27/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/08/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/08/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/08/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/23/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/30/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/29/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/29/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/29/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/29/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/29/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/29/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/29/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/29/2022
RFNT
REFUSAL PROCESSED BY IB
09/05/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/18/2022
RFRR
REFUSAL PROCESSED BY MPU
08/18/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/28/2022
CNRT
NON-FINAL ACTION WRITTEN
07/27/2022
DOCK
ASSIGNED TO EXAMINER
07/13/2022
MAFR
APPLICATION FILING RECEIPT MAILED
12/21/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/17/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/16/2021
Continuous trademark protection
Get notified about every new filing that threatens ARTICE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.